Your browser doesn't support javascript.
loading
The effect of cladribine tablets in people with more active multiple sclerosis: a plain language summary.
Vermersch, Patrick; Galazka, Andrew; Dangond, Fernando; Damian, Doris; Wong, Schiffon L; Jack, Dominic; Harty, Gerard.
Affiliation
  • Vermersch P; Univ. Lille, INSERM U1172, Lille Neurosciences & Cognition, CHU Lille, FHU Precise, Lille, France.
  • Galazka A; Merck Healthcare KGaA, Darmstadt, Germany.
  • Dangond F; EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Damian D; EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Wong SL; EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA.
  • Jack D; Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA.
  • Harty G; Merck Healthcare KGaA, Darmstadt, Germany.
Neurodegener Dis Manag ; 12(6): 285-293, 2022 12.
Article in En | MEDLINE | ID: mdl-35920065
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials Limits: Humans Language: En Journal: Neurodegener Dis Manag Year: 2022 Document type: Article Affiliation country: France Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Clinical_trials Limits: Humans Language: En Journal: Neurodegener Dis Manag Year: 2022 Document type: Article Affiliation country: France Country of publication: United kingdom